
Scientists rely on a wide array of cells as experimental models for research
Advanced oncology models
HCMI cell models
We are continually adding 2-D and 3-D patient-derived cancer models to our portfolio. These next-generation models include both common as well as rare and understudied examples of cancer from numerous tissues.
Immuno-oncology models
Explore our checkpoint luciferase reporter cells, CAR-T target luciferase reporter cells, THP-1 reporter cells, and primary immune cells that support the development of immuno-oncology therapies.